PFIZER INC - 20 Mar 2023 Form 3 Insider Report for Zura Bio Ltd (ZURA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
30 Mar 2023, 18:10:14 UTC
Prior SEC filing
23 Mar 2023
Next SEC filing
05 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
PFIZER INC. By: /s/Susan Grant, Assistant Secretary

Key filing fact

PFIZER INC filed Form 3 for Zura Bio Ltd (ZURA) on 30 Mar 2023.

Key facts

  • This page summarizes PFIZER INC's Form 3 filing for Zura Bio Ltd (ZURA).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 30 Mar 2023, 18:10.

Change

  • Previous filing in this sequence was filed on 23 Mar 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZURA holding

Class A Ordinary Shares, $0.0001 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,970,022
Date
20 Mar 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On March 20, 2023, Zura Bio Limited, a limited company incorporated under the laws of England and Wales, JATT Acquisition Corp, a Cayman Islands exempted company ("JATT"), JATT Merger Sub, a Cayman Islands exempted company and wholly owned subsidiary of JATT, JATT Merger Sub 2, a Cayman Islands exempted company and wholly owned subsidiary of JATT, and Zura Bio Holdings Ltd, a Cayman Islands exempted company, consummated the closing of the transactions contemplated by the Business Combination Agreement, dated June 16, 2022, as amended (the "Business Combination Agreement"), pursuant to which the Reporting Person received the reported securities.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .